Myriad Genetics Adds Folate Receptor Alpha to Precise™ Oncology Solutions Portfolio to Expand Treatment Options for Women Living with Ovarian Cancer
ソース:
Nasdaq GlobeNewswire
/
24 5 2023 15:05:00 America/Chicago
N/A
シェアする